PTC Therapeutics, Inc. (PTCT)
63.20
+0.64
(+1.02%)
USD |
NASDAQ |
Oct 09, 11:20
PTC Therapeutics Profit Margin (Quarterly) : 23.16% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.16% |
| March 31, 2026 | -1.03% |
| December 31, 2025 | -81.96% |
| September 30, 2025 | 7.53% |
| June 30, 2025 | -36.25% |
| March 31, 2025 | 73.68% |
| December 31, 2024 | -30.91% |
| September 30, 2024 | -54.20% |
| June 30, 2024 | -53.12% |
| March 31, 2024 | -43.58% |
| December 31, 2023 | -50.74% |
| September 30, 2023 | -67.64% |
| June 30, 2023 | -93.02% |
| March 31, 2023 | -63.05% |
| December 31, 2022 | -102.1% |
| September 30, 2022 | -50.35% |
| June 30, 2022 | -91.88% |
| March 31, 2022 | -85.20% |
| December 31, 2021 | -86.71% |
| September 30, 2021 | -96.31% |
| June 30, 2021 | -101.5% |
| March 31, 2021 | -109.1% |
| December 31, 2020 | -62.55% |
| September 30, 2020 | -58.86% |
| June 30, 2020 | -241.1% |
| Date | Value |
|---|---|
| March 31, 2020 | -165.1% |
| December 31, 2019 | -80.53% |
| September 30, 2019 | -84.01% |
| June 30, 2019 | -48.86% |
| March 31, 2019 | -134.6% |
| December 31, 2018 | -55.98% |
| September 30, 2018 | -95.11% |
| June 30, 2018 | -13.85% |
| March 31, 2018 | -34.36% |
| December 31, 2017 | 1.63% |
| September 30, 2017 | -80.61% |
| June 30, 2017 | -36.44% |
| March 31, 2017 | -109.5% |
| December 31, 2016 | -106.4% |
| September 30, 2016 | -153.0% |
| June 30, 2016 | -248.9% |
| March 31, 2016 | -218.2% |
| December 31, 2015 | -400.1% |
| September 30, 2015 | -442.1% |
| June 30, 2015 | -566.3% |
| March 31, 2015 | -506.7% |
| December 31, 2014 | -215.4% |
| September 30, 2014 | -1.61K% |
| June 30, 2014 | -1.50K% |
| March 31, 2014 | -153.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 3.72% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
| Arcturus Therapeutics Holdings, Inc. | -2.70K% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -1.34% |
| Return on Invested Capital | -13.96% |
| Gross Profit Margin (Quarterly) | 91.19% |
| Operating Margin (Quarterly) | 41.32% |
| Return on Net Operating Assets | -4.56% |